Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOS-PROST
NCT07902427Phase 4Completed
- Sponsor
- Hospital Universitari MútuaTerrassa
- Start
- Jan 2022
- Primary completion
- Mar 2026
- Countries
- 1
01
Overview
A Phase 4 trial of fosfomycin in Acute Bacterial Prostatitis (ABP), sponsored by Hospital Universitari MútuaTerrassa. Started Jan 2022; status: completed.
02
Drugs
fosfomycin
03
Conditions
Acute Bacterial Prostatitis (ABP)
Beyond the preview
Go deeper on NCT07902427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07902427.